It could be concluded that this meta-analysis showed that statins can be effective in reducing CRP and hs-CRP levels in patients with CVDs, particularly those with ACS, CAD, stable atherosclerotic plaques, unstable angina, and MI. This evidence concerns the gene CRP and angina pectoris.